KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $471.1 million.

  • Cme's Other Accumulated Expenses fell 290.6% to $471.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $471.1 million, marking a year-over-year decrease of 290.6%. This contributed to the annual value of $2.6 billion for FY2024, which is 1739.1% down from last year.
  • Cme's Other Accumulated Expenses amounted to $471.1 million in Q3 2025, which was down 290.6% from $544.5 million recorded in Q2 2025.
  • Cme's 5-year Other Accumulated Expenses high stood at $3.1 billion for Q4 2023, and its period low was $379.1 million during Q2 2021.
  • For the 5-year period, Cme's Other Accumulated Expenses averaged around $945.8 million, with its median value being $593.2 million (2023).
  • Per our database at Business Quant, Cme's Other Accumulated Expenses plummeted by 4362.83% in 2021 and then surged by 3939.78% in 2022.
  • Quarter analysis of 5 years shows Cme's Other Accumulated Expenses stood at $1.7 billion in 2021, then skyrocketed by 39.4% to $2.3 billion in 2022, then soared by 36.2% to $3.1 billion in 2023, then fell by 17.39% to $2.6 billion in 2024, then plummeted by 81.8% to $471.1 million in 2025.
  • Its last three reported values are $471.1 million in Q3 2025, $544.5 million for Q2 2025, and $625.5 million during Q1 2025.